Newton, MA, United States of America

Felicitex Therapeutics, Inc.


USPTO Granted Patents = 4


Trademarks = 1

Forward Citations = 3

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Maria Vilenchik (4 out of 4 patents)

silverMedal Michael Frid (4 out of 5 patents)

bronzeMedal Alexandra Kuznetsova (4 out of 4 patents)

4.  Yuriy Gankin (3 out of 3 patents)

5.  Marc Duey (3 out of 3 patents)

6.  Charles-Henry Fabritius (1 out of 6 patents)

7.  Agnieszka Dreas (1 out of 2 patents)

8.  Andrzej Dzienia (1 out of 1 patent)

9.  Anna Buda (1 out of 1 patent)

10.  Georgiy Kachkovskyi (1 out of 1 patent)

11.  Urszula Kulesza (1 out of 1 patent)

12.  Katarzyna Kucwaj-Brysz (1 out of 1 patent)

13.  Agnieszka Szamborska-Gbur (1 out of 1 patent)

14.  Wojciech Czardybon (1 out of 5 patents)

15.  Michal Galezowski (1 out of 6 patents)


4 patents:

Company Overview
Felicitex Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapeutics for the treatment of various diseases. With a strong emphasis on research and development, Felicitex is committed to bringing novel treatments to market that improve the lives of patients. The company's pipeline includes promising candidates for a range of conditions, with a particular focus on rare diseases and unmet medical needs.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#69 in Newton, MA

#3,313 in Massachusetts

#60,641 in US

Newton, MA (US)
Newton, MA, United States of America
Forward Citations = 3

15 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Felicitex Therapeutics, Inc.. Retrieved from https://idiyas.com/company/felicitex-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…